Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Smart textile lighting/display system with multifunctional fibre devices for large scale smart home and IoT applications.
Choi HW, Shin DW, Yang J, Lee S, Figueiredo C, Sinopoli S, Ullrich K, Jovančić P, Marrani A, Momentè R, Gomes J, Branquinho R, Emanuele U, Lee H, Bang SY, Jung SM, Han SD, Zhan S, Harden-Chaters W, Suh YH, Fan XB, Lee TH, Chowdhury M, Choi Y, Nicotera S, Torchia A, Moncunill FM, Candel VG, Durães N, Chang K, Cho S, Kim CH, Lucassen M, Nejim A, Jiménez D, Springer M, Lee YW, Cha S, Sohn JI, Igreja R, Song K, Barquinha P, Martins R, Amaratunga GAJ, Occhipinti LG, Chhowalla M, Kim JM. Choi HW, et al. Among authors: nejim a. Nat Commun. 2022 Feb 10;13(1):814. doi: 10.1038/s41467-022-28459-6. Nat Commun. 2022. PMID: 35145096 Free PMC article.
Truly form-factor-free industrially scalable system integration for electronic textile architectures with multifunctional fiber devices.
Lee S, Choi HW, Figueiredo CL, Shin DW, Moncunill FM, Ullrich K, Sinopoli S, Jovančić P, Yang J, Lee H, Eisenreich M, Emanuele U, Nicotera S, Santos A, Igreja R, Marrani A, Momentè R, Gomes J, Jung SM, Han SD, Bang SY, Zhan S, Harden-Chaters W, Suh YH, Fan XB, Lee TH, Jo JW, Kim Y, Costantino A, Candel VG, Durães N, Meyer S, Kim CH, Lucassen M, Nejim A, Jiménez D, Springer M, Lee YW, An GH, Choi Y, Sohn JI, Cha S, Chhowalla M, Amaratunga GAJ, Occhipinti LG, Barquinha P, Fortunato E, Martins R, Kim JM. Lee S, et al. Among authors: nejim a. Sci Adv. 2023 Apr 21;9(16):eadf4049. doi: 10.1126/sciadv.adf4049. Epub 2023 Apr 21. Sci Adv. 2023. PMID: 37083532 Free PMC article.
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Bergamino MA, López-Knowles E, Morani G, Tovey H, Kilburn L, Schuster EF, Alataki A, Hills M, Xiao H, Holcombe C, Skene A, Robertson JF, Smith IE, Bliss JM, Dowsett M, Cheang MCU; POETIC investigators. Bergamino MA, et al. EBioMedicine. 2022 Sep;83:104205. doi: 10.1016/j.ebiom.2022.104205. Epub 2022 Aug 16. EBioMedicine. 2022. PMID: 35985932 Free PMC article.
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators. Cuzick J, et al. Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12. Lancet. 2014. PMID: 24333009 Free article. Clinical Trial.
Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Mieog JS, Morden JP, Bliss JM, Coombes RC, van de Velde CJ; IES Steering Committee. Mieog JS, et al. Lancet Oncol. 2012 Apr;13(4):420-32. doi: 10.1016/S1470-2045(11)70328-X. Epub 2012 Jan 20. Lancet Oncol. 2012. PMID: 22265698 Clinical Trial.
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG). Regan MM, et al. Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20. Lancet Oncol. 2011. PMID: 22018631 Free PMC article. Clinical Trial.
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Chirgwin J, Sun Z, Smith I, Price KN, Thürlimann B, Ejlertsen B, Bonnefoi H, Regan MM, Goldhirsch A, Coates AS; BIG 1-98 Collaborative and International Breast Cancer Study Groups. Chirgwin J, et al. Breast Cancer Res Treat. 2012 Jan;131(1):295-306. doi: 10.1007/s10549-011-1741-6. Epub 2011 Sep 4. Breast Cancer Res Treat. 2012. PMID: 21892704 Free PMC article. Clinical Trial.
21 results